Insmed (INSM) EBT (2010 - 2026)
Insmed (INSM) posted quarterly EBT of -$162.1 million for Q1 2026, up 36.6% year-over-year from -$118.7 million in Q1 2025, and up 50.42% quarter-over-quarter from -$326.9 million in Q4 2025.
Insmed (INSM) EBT (2010 - 2026) Analysis & Trends
Insmed's EBT history runs 17 years deep, the most recent figure standing at -$162.1 million for Q1 2026.
- In Q1 2026, EBT rose 36.6% year-over-year to -$162.1 million; the TTM figure through Mar 2026 stood at -$1.2 billion (down 16.74% YoY), while the FY2025 annual figure was -$1.3 billion, down 39.74% from the prior year.
- EBT for Q1 2026 stood at -$162.1 million, up from -$326.9 million in the prior quarter.
- The five-year high for EBT was -$94.2 million in Q1 2022, with the low at -$368.7 million in Q3 2025.
- The 5-year median for EBT is -$185.1 million (2023), against an average of -$210.1 million.
- The sharpest annual moves came in 2023 and 2026: EBT sank 156.75% in 2023, then surged 36.6% in 2026.
- Insmed's EBT stood at -$160.0 million in 2022, then retreated by 15.67% to -$185.1 million in 2023, then decreased by 26.6% to -$234.3 million in 2024, then plunged by 39.55% to -$326.9 million in 2025, then soared by 50.42% to -$162.1 million in 2026.
- Business Quant data shows INSM's EBT at -$162.1 million in Q1 2026, -$326.9 million in Q4 2025, and -$368.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn | -294.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -11.37 Mn |
| Mar 31, 2026 | -162.10 Mn |
| Dec 31, 2025 | -326.93 Mn |
| Sep 30, 2025 | -368.70 Mn |
| Jun 30, 2025 | -320.44 Mn |
| Mar 31, 2025 | -255.67 Mn |
| Dec 31, 2024 | -234.28 Mn |
| Sep 30, 2024 | -219.51 Mn |
| Jun 30, 2024 | -299.77 Mn |
| Mar 31, 2024 | -156.50 Mn |
| Dec 31, 2023 | -185.06 Mn |
| Sep 30, 2023 | -158.39 Mn |
| Jun 30, 2023 | -244.28 Mn |
| Mar 31, 2023 | -159.28 Mn |
| Dec 31, 2022 | -160.00 Mn |
| Sep 30, 2022 | -130.77 Mn |
| Jun 30, 2022 | -95.14 Mn |
| Mar 31, 2022 | -94.24 Mn |
| Dec 31, 2021 | -113.02 Mn |
| Sep 30, 2021 | -115.29 Mn |